Document Detail


Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial).
MedLine Citation:
PMID:  15165935     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The relation of cardiac troponin-I (cTnI) to clinical outcomes was examined in patients with decompensated heart failure and concomitant acute coronary syndrome enrolled into the Randomized Intravenous TeZosentan 4 (RITZ-4) study. RITZ-4 was a multicenter, randomized, double-blind, placebo-controlled trial of the endothelin receptor antagonist tezosentan in patients admitted with acute heart failure and concomitant acute coronary syndrome. One hundred ninety-two patients were enrolled in this study. Patients with baseline cTnI values were included in this analysis, and the relation between cTnI and the composite clinical primary end point of RITZ-4 was evaluated.
Authors:
Wendy A Gattis; Christopher M O'Connor; Vic Hasselblad; Kirkwood F Adams; Isaac Kobrin; Mihai Gheorghiade
Related Documents :
3743145 - Reperfusion arrhythmias during coronary reperfusion therapy in man. clinical and angiog...
10456205 - Multisite study of a second generation whole blood rapid assay for cardiac troponin t.
21516285 - Local thrombolysis for successful treatment of acute stroke in an adolescent with cardi...
15736585 - Cardiac troponins in renal insufficiency and other non-ischemic cardiac conditions.
8888655 - Differences in treatment of acute myocardial infarction by sex, age, and other factors ...
3743145 - Reperfusion arrhythmias during coronary reperfusion therapy in man. clinical and angiog...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The American journal of cardiology     Volume:  93     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2004 Jun 
Date Detail:
Created Date:  2004-05-28     Completed Date:  2004-06-25     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1436-7, A10     Citation Subset:  AIM; IM    
Affiliation:
Duke Clinical Research Institute, Duke University Medical Center, 2400 N. Pratt Street, Box 17969, Durham, NC 27710, USA. wendy.gattis@duke.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Aged
Coronary Disease / blood*,  complications
Female
Heart Failure / blood*,  complications
Humans
Male
Multicenter Studies as Topic
Pyridines / therapeutic use
Randomized Controlled Trials as Topic
Receptors, Endothelin / antagonists & inhibitors
Retrospective Studies
Risk Factors
Tetrazoles / therapeutic use
Troponin I / blood*
Vasodilator Agents / therapeutic use
Chemical
Reg. No./Substance:
0/Pyridines; 0/Receptors, Endothelin; 0/Tetrazoles; 0/Troponin I; 0/Vasodilator Agents; 0/tezosentan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of effects of losartan, irbesartan, and candesartan on flow-mediated brachial artery dila...
Next Document:  Effect of perindopril on platelet nitric oxide resistance in patients with chronic heart failure sec...